About: http://data.cimple.eu/news-article/6e1f55ea21d2ea1648e97528d2ec70ca3dbcc02941644c67650231e7

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/6e1f55ea21d2ea1648e97528d2ec70ca3dbcc02941644c67650231e7 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	AstraZeneca's Covid-19 vaccine is 79 percent effective at preventing the disease and does not increase the risk of blood clots, the biotech firm said Monday, following its US phase III efficiency trials. The shot was also 80 percent effective for the over 65s, it said. Several countries had advised against administering the jab to older people due to a lack of data among elderly participants in previous trials. bur-mtp/rbu
schema:headline	AstraZeneca says vaccine 79% effective, no blood clot risk after US trial
schema:mentions	The Shot Clinical trial Thrombus Jab AstraZeneca Vaccine Coronavirus disease 2019 Venous thrombosis
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-22 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.123 as of May 22 2025

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 8 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software